中药大品种二次开发关键技术研究进展及相关思考:以血府逐瘀制剂为例OA
Research Progress and Related Thoughts on Key Technologies for the Secondary Development of Large Varieties of Traditional Chinese Medicine:A Case Study of Xuefu Zhuyu Preparations
传统中药制剂由于成分复杂、药效物质基础模糊、质量可控性不足及作用机制不明确,存在潜在安全隐患,影响其普及化及国际化.为应对上述问题,中药领域逐步形成了以"老药新用、经典焕新"为核心理念的系统化再开发思路,推动中药大品种的深入挖掘与再评价.随着人工智能、过程分析技术、网络药理学、质谱联用技术以及质量源于设计理念在中药研究中的深入应用,中药大品种的现代化与科学化发展迎来新机遇.该文以血府逐瘀制剂这一典型活血化瘀类中药大品种为研究对象,首次系统梳理其二次开发涉及的关键技术体系,包括质量控制、机制解析、药效明确、疗效提升与国际认可5个维度.同时,结合人工智能及大语言模型的应用实例,优化相关技术路径并提炼共性经验,探讨中药大品种未来的发展方向,为同类品种的现代化升级提供参考范式.
Traditional Chinese medicine preparations still have potential safety hazards due to com-plex components,vague pharmacodynamic material basis,insufficient quality controllability and un-clear mechanism of action,which affect their popularization and internationalization.In response to the above problems,the field of traditional Chinese medicine has gradually formed a systematic re-development idea with the core concept of"new use of old drugs and renewal of classics",and pro-moted the in-depth excavation and re-evaluation of large varieties of traditional Chinese medicine.With the in-depth application of artificial intelligence,process analysis technology,network pharma-cology,mass spectrometry technology and quality by design concept in the research of traditional Chi-nese medicine,the modernization and scientific development of large varieties of traditional Chinese medicine ushered in new opportunities.In this paper,Xuefu Zhuyu preparation,a typical large vari-ety of traditional Chinese medicine for promoting blood circulation and removing blood stasis,was taken as the research object.For the first time,the key technical system involved in its secondary de-velopment was systematically sorted out,including five dimensions:quality control,mechanism analysis,clear efficacy,efficacy improvement and international recognition.At the same time,combined with the application examples of artificial intelligence and large language model,the rele-vant technical paths were optimized and the common experience was refined to explore the future de-velopment direction of large varieties of traditional Chinese medicine,so as to provide a reference paradigm for the modernization and upgrading of similar varieties.
沙鑫;常淏;宋纹;余河水;李正;李文龙
天津中医药大学 中药制药工程学院,天津 301617||现代中医药海河实验室,天津 301617天津中医药大学 中药制药工程学院,天津 301617||现代中医药海河实验室,天津 301617天津宏仁堂药业有限公司,天津 300380天津中医药大学 中药制药工程学院,天津 301617||现代中医药海河实验室,天津 301617||天津市中药智能制药与绿色制药重点实验室,天津 301617天津中医药大学 中药制药工程学院,天津 301617||现代中医药海河实验室,天津 301617||天津市中药智能制药与绿色制药重点实验室,天津 301617天津中医药大学 中药制药工程学院,天津 301617||现代中医药海河实验室,天津 301617||天津市中药智能制药与绿色制药重点实验室,天津 301617
化学化工
中药大品种血府逐瘀制剂二次开发过程分析技术人工智能
large varieties of traditional Chinese medicineXuefu Zhuyu preparationssecondary developmentprocess analytical technologyartificial intelligence
《分析测试学报》 2026 (6)
1174-1187,14
国家重点研发计划(2023YFC3504502)现代中医药海河实验室-天津宏仁堂药业有限公司合作项目(XMH2022004)资助
评论